How to initiate and monitor infusional lidocaine for severe and/or neuropathic pain.
Ferrini
Rebecca
R
Edgemoor Hospital, Santee, California 92071, USA. rebecca.ferrini@sdcounty.ca.gov
Paice
Judith A
JA
D000779:Anesthetics, Local / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008012:Lidocaine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D018242:Neuroectodermal Tumors, Primitive / Q000150:complications; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D000779:Anesthetics, Local; D008012:Lidocaine